FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994930872> ?p ?o ?g. }

• W1994930872 abstract "Recent studies have highlighted the potentially harmful effects of short-acting calcium channel blockers, especially of the dihydropyridine type, in patients with coronary heart disease. Some have argued that long-acting calcium channel blockers are safer, but few outcome data exist. The objective of the study was to compare the occurrence of adverse outcomes among recipients of long-acting versus short-acting calcium channel blockers, with dihydropyridines and non-dihydropyridines compared separately.The New Jersey Medicare population.A retrospective cohort study using linked Medicare and drug claims data.Older survivors of acute myocardial infarction (MI) occurring in 1989 and 1990. Eligible subjects had survived at least 30 days after the MI, participated in Medicare and a drug benefits program, and were prescribed a single type of either a long-acting or a short-acting calcium channel blocker within 90 days after the MI.The two outcome measures were rates of all-cause mortality and cardiac rehospitalization. Using separate Cox regression models for dihydropyridines (nifedipine, nicardipine) and non-dihydropyridines (diltiazem, verapamil), we examined these outcomes for recipients of long-acting compared with short-acting calcium channel blockers.Of the 833 patients eligible for the study, 160 were prescribed long-acting and 673 short-acting calcium channel blockers. Clinical characteristics of long-acting and short-acting users were comparable. During 2 years of follow-up, 221 deaths and 300 rehospitalizations occurred. Controlling for age, sex, race, and indicators of disease severity and comorbidity, the relative risk of dying for recipients of long-acting, compared with short-acting, dihydropyridines was .42 (95% confidence interval (CI), 0.21-0.86). For cardiac rehospitalization, the relative risk was 0.57 (95% CI, 0.34-0.94). For the long-acting versus short-acting nondihydropyridines, the adjusted relative risk of dying was 1.43 (95% CI, 0.88-2.32), and for cardiac rehospitalization, .65 (95% CI, 0.40-1.05).Use of long-acting dihydropyridine calcium channel blockers after acute MI was associated with substantially lower rates of cardiac rehospitalization and death compared with use of their short-acting counterparts. More data are needed to address the possibility that long-acting, compared with short-acting, non-dihydropyridines could decrease rehospitalization rates but increase mortality." @default.
• W1994930872 created "2016-06-24" @default.
• W1994930872 creator A5010392035 @default.
• W1994930872 creator A5024182885 @default.
• W1994930872 creator A5030151797 @default.
• W1994930872 creator A5040481149 @default.
• W1994930872 creator A5067206764 @default.
• W1994930872 creator A5074451946 @default.
• W1994930872 creator A5077513309 @default.
• W1994930872 creator A5077719091 @default.
• W1994930872 date "1999-05-01" @default.
• W1994930872 modified "2023-09-24" @default.
• W1994930872 title "Effects of Long-Acting Versus Short-Acting Calcium Channel Blockers Among Older Survivors of Acute Myocardial Infarction" @default.
• W1994930872 cites W1965893204 @default.
• W1994930872 cites W1968127966 @default.
• W1994930872 cites W1971027475 @default.
• W1994930872 cites W1979082324 @default.
• W1994930872 cites W2028294998 @default.
• W1994930872 cites W2047895902 @default.
• W1994930872 cites W2058645062 @default.
• W1994930872 cites W2083625183 @default.
• W1994930872 cites W2085258016 @default.
• W1994930872 cites W2092805838 @default.
• W1994930872 cites W2093009820 @default.
• W1994930872 cites W2106073810 @default.
• W1994930872 cites W2114634962 @default.
• W1994930872 cites W2170807373 @default.
• W1994930872 cites W2318480619 @default.
• W1994930872 cites W2727581825 @default.
• W1994930872 cites W4231250029 @default.
• W1994930872 cites W4292229884 @default.
• W1994930872 cites W4293282543 @default.
• W1994930872 cites W4302332127 @default.
• W1994930872 doi "https://doi.org/10.1111/j.1532-5415.1999.tb02562.x" @default.
• W1994930872 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10323641" @default.
• W1994930872 hasPublicationYear "1999" @default.
• W1994930872 type Work @default.
• W1994930872 sameAs 1994930872 @default.
• W1994930872 citedByCount "12" @default.
• W1994930872 countsByYear W19949308722012 @default.
• W1994930872 countsByYear W19949308722015 @default.
• W1994930872 countsByYear W19949308722022 @default.
• W1994930872 crossrefType "journal-article" @default.
• W1994930872 hasAuthorship W1994930872A5010392035 @default.
• W1994930872 hasAuthorship W1994930872A5024182885 @default.
• W1994930872 hasAuthorship W1994930872A5030151797 @default.
• W1994930872 hasAuthorship W1994930872A5040481149 @default.
• W1994930872 hasAuthorship W1994930872A5067206764 @default.
• W1994930872 hasAuthorship W1994930872A5074451946 @default.
• W1994930872 hasAuthorship W1994930872A5077513309 @default.
• W1994930872 hasAuthorship W1994930872A5077719091 @default.
• W1994930872 hasConcept C126322002 @default.
• W1994930872 hasConcept C164705383 @default.
• W1994930872 hasConcept C167135981 @default.
• W1994930872 hasConcept C2776741139 @default.
• W1994930872 hasConcept C2777022698 @default.
• W1994930872 hasConcept C2778043224 @default.
• W1994930872 hasConcept C2778198053 @default.
• W1994930872 hasConcept C2779066535 @default.
• W1994930872 hasConcept C2780356492 @default.
• W1994930872 hasConcept C2781212610 @default.
• W1994930872 hasConcept C2908647359 @default.
• W1994930872 hasConcept C500558357 @default.
• W1994930872 hasConcept C519063684 @default.
• W1994930872 hasConcept C71924100 @default.
• W1994930872 hasConcept C72563966 @default.
• W1994930872 hasConcept C85520022 @default.
• W1994930872 hasConcept C99454951 @default.
• W1994930872 hasConceptScore W1994930872C126322002 @default.
• W1994930872 hasConceptScore W1994930872C164705383 @default.
• W1994930872 hasConceptScore W1994930872C167135981 @default.
• W1994930872 hasConceptScore W1994930872C2776741139 @default.
• W1994930872 hasConceptScore W1994930872C2777022698 @default.
• W1994930872 hasConceptScore W1994930872C2778043224 @default.
• W1994930872 hasConceptScore W1994930872C2778198053 @default.
• W1994930872 hasConceptScore W1994930872C2779066535 @default.
• W1994930872 hasConceptScore W1994930872C2780356492 @default.
• W1994930872 hasConceptScore W1994930872C2781212610 @default.
• W1994930872 hasConceptScore W1994930872C2908647359 @default.
• W1994930872 hasConceptScore W1994930872C500558357 @default.
• W1994930872 hasConceptScore W1994930872C519063684 @default.
• W1994930872 hasConceptScore W1994930872C71924100 @default.
• W1994930872 hasConceptScore W1994930872C72563966 @default.
• W1994930872 hasConceptScore W1994930872C85520022 @default.
• W1994930872 hasConceptScore W1994930872C99454951 @default.
• W1994930872 hasLocation W19949308721 @default.
• W1994930872 hasLocation W19949308722 @default.
• W1994930872 hasOpenAccess W1994930872 @default.
• W1994930872 hasPrimaryLocation W19949308721 @default.
• W1994930872 hasRelatedWork W17926688 @default.
• W1994930872 hasRelatedWork W1994930872 @default.
• W1994930872 hasRelatedWork W2026813629 @default.
• W1994930872 hasRelatedWork W2041785705 @default.
• W1994930872 hasRelatedWork W2048356388 @default.
• W1994930872 hasRelatedWork W2130097346 @default.
• W1994930872 hasRelatedWork W2148282970 @default.
• W1994930872 hasRelatedWork W2316376689 @default.
• W1994930872 hasRelatedWork W2413265658 @default.
• W1994930872 hasRelatedWork W2183172978 @default.
• W1994930872 isParatext "false" @default.

• next